Hill City Capital
Overview
Hill City Capital is a US-based investment adviser registered with the SEC. The firm operates as a hedge fund manager employing a long/short equity strategy and also makes private equity and venture capital investments in various sectors, including healthcare and biotechnology. It manages pooled investment vehicles for its clients.
Portfolio Companies
4
Website
cityhill.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Maze Therapeutics | Jan 2022 | Series C | Co-investor |
| Boundless Bio | May 2023 | Series C | Co-investor |
| SafeRide Health | Oct 2023 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Hill City Capital based?
Hill City Capital is headquartered in Boston, Massachusetts, United States.
When was Hill City Capital founded?
Founding year information for Hill City Capital is not publicly available.
How many portfolio companies does Hill City Capital have?
Hill City Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in Hill City Capital's portfolio?
Portfolio companies visible on Caplight include Maze Therapeutics, Boundless Bio, SafeRide Health.
What was Hill City Capital's most recent investment shown here?
Hill City Capital's most recent investment in this portfolio sample was in SafeRide Health in 2023.
What sectors does Hill City Capital focus on?
Hill City Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics.
What company stages does Hill City Capital focus on?
Hill City Capital typically invests at the Mid stage.
What is Hill City Capital's AUM?
Hill City Capital's assets under management are estimated between $2.0B and $2.9B.